Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Hypertensive Retinopathy Secondary to Anlotinib Treatment.

< BACK TO ARCHIVE


2020


Front Pharmacol


http://www.ncbi.nlm.nih.gov/pubmed/32581802?dopt=Abstract


11

Hypertensive Retinopathy Secondary to Anlotinib Treatment.

Authors

Hypertensive Retinopathy Secondary to Anlotinib Treatment.
Zhang X, Peng L, Xie Q, Wu Q, Sheng X
Front Pharmacol. 2020; 11:843.
PMID: 32581802.

Abstract

We report a case of a middle-aged woman who developed hypertensive retinopathy following oral administration of Anlotinib.
Read This Paper